These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16741343)

  • 21. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The genetic medicine network in Quebec: An integrated program for diagnosis, counseling and treatment of hereditary metabolic diseases].
    Laberge C; Scriver CR; Clow CL; Dufour D
    Union Med Can; 1975 Mar; 104(3):428-32. PubMed ID: 1162775
    [No Abstract]   [Full Text] [Related]  

  • 23. A cost-benefit analysis of the Quebec Network of Genetic Medicine.
    Dagenais DL; Courville L; Dagenais MG
    Soc Sci Med; 1985; 20(6):601-7. PubMed ID: 3923626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population screening for reproductive risk for single gene disorders in Australia: now and the future.
    Delatycki MB
    Twin Res Hum Genet; 2008 Aug; 11(4):422-30. PubMed ID: 18637742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tay-Sachs disease as a model for screening inborn errors.
    Blitzer MG; McDowell GA
    Clin Lab Med; 1992 Sep; 12(3):463-80. PubMed ID: 1355703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eugenics--sacred and profane.
    Rosen C
    New Atlantis; 2003; (2):79-89. PubMed ID: 15584198
    [No Abstract]   [Full Text] [Related]  

  • 27. Population screening in the age of genomic medicine.
    Khoury MJ; McCabe LL; McCabe ER
    N Engl J Med; 2003 Jan; 348(1):50-8. PubMed ID: 12510043
    [No Abstract]   [Full Text] [Related]  

  • 28. Geneticization: the Cyprus paradigm.
    Hoedemaekers R; ten Have H
    J Med Philos; 1998 Jun; 23(3):274-87. PubMed ID: 9736189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic services and research in the state of Minas Gerais, Brazil.
    Aguiar MJ
    Community Genet; 2004; 7(2-3):117-20. PubMed ID: 15539826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic Carrier Screening in the Twenty-first Century.
    Yao R; Goetzinger KR
    Clin Lab Med; 2016 Jun; 36(2):277-88. PubMed ID: 27235912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.
    Bishop Hubbard H
    Policy Polit Nurs Pract; 2007 Aug; 8(3):201-9. PubMed ID: 18178927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening semen donors for hereditary diseases. The Fairfax cryobank experience.
    Bick D; Fugger EF; Pool SH; Hazelrigg WB; Yadvish KN; Spence WC; Maddalena A; Howard-Peebles PN; Schulman JD
    J Reprod Med; 1998 May; 43(5):423-8. PubMed ID: 9610465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Problems in medical genetic services as viewed from Israel.
    Goodman RM
    Public Health Rep; 1984; 99(5):460-4. PubMed ID: 6435158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of homozygous beta thalassemia by premarital screening and prenatal diagnosis in India.
    Tamhankar PM; Agarwal S; Arya V; Kumar R; Gupta UR; Agarwal SS
    Prenat Diagn; 2009 Jan; 29(1):83-8. PubMed ID: 19090545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence and carrier frequency of Tay-Sachs disease in the French-Canadian population of Quebec based on retrospective data from 24 years, 1992-2015.
    Sillon G; Allard P; Drury S; Rivière JB; De Bie I
    J Genet Couns; 2020 Dec; 29(6):1173-1185. PubMed ID: 32302469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
    Zlotogora J; Leventhal A
    Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventation of thalassemia in Australia.
    Hendy J
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():94-6. PubMed ID: 11400797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic screening for reproductive purposes at school: is it a good strategy?
    Frumkin A; Zlotogora J
    Am J Med Genet A; 2008 Jan; 146A(2):264-9. PubMed ID: 18080324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on cystic fibrosis screening.
    Goetzinger KR; Cahill AG
    Clin Lab Med; 2010 Sep; 30(3):533-43. PubMed ID: 20638569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.